Fig. 5.
The hyperglycemic and hyperinsulinemic effects of RVLM microinjection of the TRH analog RX77368, the substance P analog DiMe-C7 [pGlu5, Mephe8, MeGly9]substance P5-11, and angiotensin II (all at 150 pmol, data of the TRH analog are adapted from Fig. 2) in Wistar rats. Each point represents mean ± SEM of the number of rats indicated in the parenthesis. * P < 0.05 compared with the value of the same time point in TRH analog RX77368 injected rats. # P< 0.05 compared with the basal levels of the same group.